Substantial studies suggest that externalization of erythrocyte PS in SCD and abnormal CD239 (Lu/BCAM) phosphorylation on red blood cells from polycythemia vera (PV) patients may be crucial in these disorders [22, 23]. This evidence concerns the gene BCAM and acquired polycythemia vera.